GSK3528869A (Bepirovirsen) for Chronic Hepatitis B Drug Pipeline Research 2024: Market Size, Forecast, and Emerging Insights 2019-2032 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “GSK3528869A Bepirovirsen Market Size, Forecast, and Emerging Insight – 2032” report has been added to ResearchAndMarkets.com’s... Read more.
Amprius Secures Multiple Purchase Orders from AALTO for SiMaxx™ 450 Wh/kg High-Energy Cells to Continue Record-Breaking Flights
Custom Battery Cells Provide Unparalleled Energy Density for Stratospheric HAPS Applications FREMONT, Calif.–(BUSINESS WIRE)–Amprius Technologies, Inc.... Read more.
Nemvaleukin Alfa (Previously known as ALKS 4230) Drug Landscape Report 2024: An Interleukin-2 Receptor Agonist for the Treatment of Solid Tumors – Size, Forecasts, and Insights 2019-2032 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Nemvaleukin alfa Market Size, Forecast, and Emerging Insight – 2032” report has been added to ResearchAndMarkets.com’s... Read more.
Volato Reports Operational KPIs for the First Quarter 2024
ATLANTA–(BUSINESS WIRE)–Volato Group, Inc. (“Volato,” or the “Company”) (NYSE American: SOAR), a leading private aviation company and the largest... Read more.
Cass Information Systems Reports First Quarter 2024 Results
First Quarter Results (All comparisons refer to the first quarter of 2023, except as noted) Net income of $7.2 million, or $0.52 per diluted common share. Return... Read more.
Pivot Health Launches Proprietary Short-Term Medical Insurance Product Underwritten by Pan-American Life Insurance Company
Benefits include unlimited doctor office visits, child immunizations, no hospital or emergency room copayments, and preventive care and screenings NEW YORK–(BUSINESS... Read more.
OneAZ’s Launch of Credit Flex Auto Program Backed by Open Lending
Partnership will expand access to competitive auto loans for Arizonans AUSTIN, Texas–(BUSINESS WIRE)–Open Lending Corporation (NASDAQ: LPRO) (“Open... Read more.
OPDIVO (Nivolumab) Drug Pipeline Research Report 2024: The First-in-human Immunoglobulin G4 (IgG4) PD-1 Immune Checkpoint Inhibitor Antibody – Market Size, Forecast, and Emerging Insights 2019-2032 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “OPDIVO Market Size, Forecast, and Emerging Insight – 2032” report has been added to ResearchAndMarkets.com’s... Read more.
Ladder Capital Corp to Report First Quarter 2024 Results
NEW YORK–(BUSINESS WIRE)–Ladder Capital Corp (NYSE: LADR) (“we,” “Ladder,” or the “Company”) will release its first quarter 2024 results... Read more.
Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit
HOUSTON–(BUSINESS WIRE)–Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics... Read more.